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Abstract: Reports on the relationship between comorbidity and glycemia control in diabetic 
patients are conﬂ  icting and the method of measuring comorbidity varies widely among studies. 
The aim of the present study was to evaluate the relationship between diabetes control and 
comorbidity, taking into account all comorbidities and their severity, in a primary care setting. 
We performed a retrospective descriptive study based on chart review of 96 randomly selected 
type 2 diabetic patients. Comorbidity was measured with the cumulative illness rating scale 
(CIRS), an exhaustive comorbidity index. Diabetes was considered as controlled if the mean 
value of two measurements of glycosylated hemoglobin A (HbA1c) was less than 7%. Taking 
diabetes control as the dependent variable, its relationship with the CIRS score, age, sex, 
diabetes duration, and diabetes-related complications was explored. Diabetes control was not 
signiﬁ  cantly related with the CIRS score, age, sex or diabetes severity. Diabetes duration was 
the only variable signiﬁ  cantly related to diabetes control. Our study suggests that comorbid-
ity measured with the CIRS in patients with type 2 diabetes is not a factor that prevents the 
achievement of a good glycemia control.
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Introduction
Diabetes mellitus is one of the most challenging chronic diseases (King et al 1998; 
Lipscombe and Hux 2007) associated with signiﬁ  cant morbidity and mortality (Baker 
et al 2008; Pinto et al 2008). In order to avoid or delay microvascular complications, 
a strict metabolic control of blood glucose is recommended (UKPDS 1998; LeRoith 
and Smith 2005; Vermeire et al 2005). Measure of glycosylated hemoglobin A (HbA1c) 
is used to evaluate glycemia control. For the majority of diabetics, glycemia control 
is considered attained when HbA1c levels are less than 7% (Harris and Lank 2004; 
Anonymous 2008).
Many patients do not achieve optimal glycemia control (Saaddine et al 2002; 
Putzer et al 2004). Longer diabetes duration and presence of complications are both 
associated with poor glycemia control (Druss et al 2001; Putzer et al 2004; Weiner and 
Long 2004; Egede 2005; Kerr et al 2007; Kivimaki et al 2007; Parchman et al 2007; 
Suh et al 2008). The majority of diabetic patients have at least one comorbid chronic 
condition (Druss et al 2001; Egede 2005; Kivimaki et al 2007), a problem that may 
also have an impact on glycemia control. Indeed, competing situations may occur in the 
treatment of patients (Parchman et al 2007), and the presence of several symptomatic 
comorbidities may inﬂ  uence patients’ self management (Kerr et al 2007). However, 
reports on the relationship between comorbidity and glycemia control are conﬂ  icting. 
In some cases, evidence suggests that comorbidity is associated with lower glycemia 
control (Zhang et al 2000; Weiner and Long 2004; Suh et al 2008), whereas other data 
argue against any association (El-Kebbi et al 2001). These conﬂ  icting results may be 
explained by the use of different methods to measure comorbidity. In two studies, Diabetes, Metabolic Syndrome and Obesity 2008:1 34
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the Charlson comorbidity index was used (Zhang et al 2000; 
Weiner and Long 2004). However, this index was originally 
developed to predict mortality risk and includes a limited 
list of diseases. Another study used the chronic disease 
score (CDS) (El-Kebbi et al 2001), a comorbidity measure 
based on sex, age, and drugs prescribed to the patient. The 
remaining study took into account a limited number of 
conditions traditionally known as diabetes complications 
(Suh et al 2008).
Uncontrolled diabetes may result in complications such 
as nephropathy, renal failure, hypertension, congestive heart 
failure and coronary disease (ADA 2008). Therefore, any 
study on a possible association between glycemia control 
and comorbidity, in which the measure of comorbidity would 
only include such chronic conditions would be biased towards 
ﬁ  nding an association. Furthermore, in addition to the type 
of comorbidity, its severity may either cause poor glycemia 
control or be a consequence of it.
Since many diabetic patients have comorbidity (Druss 
et al 2001; Egede 2005; Kivimaki et al 2007), it is important 
to determine if comorbidity increases the difﬁ  culty to manage 
the disease and to achieve good glycemia control. Therefore, 
the aim of the present study was to evaluate the relationship 
between diabetes control and comorbidity using a compre-
hensive comorbidity index in a primary care setting.
Methods
We performed a retrospective descriptive study based on 
chart review at the family medicine unit (FMU) of the Centre 
de Santé et de Services Sociaux de Chicoutimi, Quebec, 
Canada. The study was approved by the institutional ethics 
committee.
Using the electronic laboratory database available, 
we performed a random selection of patients with type 
2 diabetes who had at least two measurements of HbA1c 
levels between January 1st, 2004 and September 1st, 2006. 
Patients diagnosed with diabetes less than a year before the 
last measurement of HbA1c and those under the care of the 
researchers involved in this study were excluded.
Three trained nurses extracted data from patients’ paper 
charts. Data extracted from the charts included sex, age, 
the last two measures of HbA1c, the presence or absence 
of diabetes-related complications, time elapsed since the 
diagnosis of diabetes (diabetes duration at the moment of 
the second measurement of HbA1c) as well as information 
about the patient’s chronic conditions necessary to score the 
cumulative illness rating scale (CIRS) (Linn et al 1968; Fortin 
et al 2005b, 2006a, 2006b). The three nurses, blinded to the 
objectives of the study, had received an half-day training in 
CIRS scoring prior to the study.
The CIRS is a measure of comorbidity that takes into 
account all medical conditions and includes the notion 
of severity (Linn et al 1968; Fortin et al 2005b, 2006a, 
2006b). It has been validated in primary care as a tool for 
quantifying comorbidity (Hudon et al 2005, 2007). The 
CIRS uses a scoring system that encompasses 14 anatomi-
cal domains (cardiac, vascular, hematological, respiratory, 
ophthalmologic–otorhinolaryngologic, upper gastroin-
testinal, lower gastrointestinal, hepatic–pancreatic, renal, 
genitourinary, musculoskeletal–tegument, neurological, 
endocrine–metabolic–breast, and psychiatric) and assigns a 
value from 0 (no condition in this domain) to 4 (extremely 
severe problem) to determine a severity score for each 
domain. In the case of multiple conditions affecting a par-
ticular domain, the highest score is given to the domain. The 
global score is the sum of each domain’s score. To use the 
CIRS as a measure of comorbidity for diabetes, this disease 
was not included in the global score of each patient.
Study groups were deﬁ  ned with a categorical variable 
(controlled/uncontrolled diabetes). Diabetes was considered 
as controlled if the mean value of the two measurements of 
HbA1c levels was less than 7%; mean values equal or greater 
than 7% were considered as uncontrolled diabetes (Harris 
and Lank 2004; Anonymous 2008).
Data analysis
The differences between patients with controlled and uncon-
trolled diabetes were tested using the t-test for continuous 
variables such as CIRS score, age and diabetes duration, 
and the Chi-square test for categorical variables like sex 
and diabetes-related complications. Then, variables with 
P   0.1 were used as covariables in a multivariable logis-
tic regression model to measure the association between 
diabetes control (dependant variable) and the CIRS score 
(independent variable).
According to various studies, the percentage of patients 
controlling their diabetes varies from 33% to 55% (Weiner 
and Long 2004; Meduru et al 2007; Suh et al 2008). When 
we estimated the sample size, we used the worst case scenario 
and anticipated a 2-to-1 ratio when comparing subjects with 
uncontrolled diabetes to subjects with controlled diabetes. 
A total sample size of 75 subjects was needed in order to 
achieve 80% statistical power, to detect a difference of 
4 points on the CIRS with a standard deviation of  5.64 (based 
on a previous study) (Fortin et al 2005a), with a two-sided 
t-test at the 5% signiﬁ  cance level (nQuery Advisor 6.01). Diabetes, Metabolic Syndrome and Obesity 2008:1 35
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We increased this sample size by 30% to account for possible 
missing data in the charts and to allow controlling for 2 to 
3 variables in the logistic regression model (requiring at least 
30 subjects in the smallest group).
Analyses were made with SPSS software (version 13.0; 
SPSS Inc., Chicago, IL) and a P value   0.05 was consid-
ered statistically signiﬁ  cant.
Results
Ninety-six charts were reviewed for this study. Patients’ char-
acteristics and the two groups of diabetic patients are presented 
in Table 1. Statistical results from the univariate analyses 
performed to measure the associations between diabetes con-
trol and the patients’ characteristics are indicated in Table 1.
Diabetes control was not signiﬁ  cantly related with the 
CIRS score, age, sex, or diabetes-related complications. 
Diabetes control was however signiﬁ  cantly related to dia-
betes duration. A logistic regression model was thus used 
to measure the association between diabetes control and the 
CIRS, by including the diabetes duration as a covariable. The 
relation was still not signiﬁ  cant (adjusted odds ratio = 0.889; 
95% conﬁ  dence interval: 0.736–1.074; p = 0.223).
Discussion
The results of this study suggest that in patients with type 
2 diabetes mellitus, the presence of comorbidity measured 
with the CIRS, is not related to glycemia control deﬁ  ned by 
HbA1c levels. The ﬁ  nding that glycemia control is associated 
with diabetes duration is similar to that of previous reports 
(Leelawattana et al 2006; Shim et al 2006; Tascona et al 
2006; Heisler et al 2007; Lopez Stewart et al 2007; Tien et al 
2008; Tikellis et al 2008).
To our knowledge, this is the first study that used 
the CIRS to measure comorbidity in order to assess the 
relationship between comorbidity and glycemia control in 
type 2 diabetic patients. The CIRS score takes into account all 
comorbidities as well as their severity, and provides a good 
assessment of other chronic diseases that may coexist with 
diabetes mellitus, being or not etiologically associated with 
it. Compared to our comorbidity measuring method, previ-
ous studies on a possible association between comorbidity 
condition and glycemia control included a limited number 
of diseases (Zhang et al 2000; Weiner and Long 2004; Suh 
et al 2008) or diseases associated to diabetes exclusively (Suh 
et al 2008). In these studies, the presence of comorbidities 
was found to be related to glycemia control. Our ﬁ  nding that 
the presence of comorbidities is not associated with glycemia 
control supports the conclusion of another study which also 
used a more comprehensive measurement of comorbidity, 
the chronic disease score (CDS) (El-Kebbi et al 2001).
It has been reported that depending on the type of comor-
bid condition they have, diabetic patients are more or less 
likely to achieve HbA1c levels under 7% (Meduru et al 2007). 
Therefore, when HbA1c less than 7% threshold is used as a 
performance measure for diabetes quality of care, assessment 
of an association between glycemia control and comorbidity 
may be inﬂ  uenced by the type of comorbid conditions. In 
fact, the likelihood of ﬁ  nding an association between poor 
glycemia control and comorbidity in patients with diabe-
tes-related complications would be higher than in patients 
without this type of complications (Meduru et al 2007). 
However, our study suggests that the presence of multiple 
chronic conditions is not a factor limiting the achievement 
of a good control of glycemia, even after taking into account 
the severity of the coexistent diseases. It has been reported 
that services received by diabetic patients do not differ based 
on comorbid illness burden (Halanych et al 2007), how-
ever diabetic patients with elevated HbA1c receive a closer 
Table 1 Comparison of patients with controlled or uncontrolled diabetes
Characteristic* Controlled diabetes (HbA1c   7%)
(n = 66)
Uncontrolled diabetes (HbA1c   7%)
(n = 30)
P
Males, n (%) 30.0 (45.0) 17.0 (57.0) 0.340†
Age, years 67.8 (10.6) 65.2 (12.4) 0.290**
Diabetes duration, years 6.7 (4.5) 11.3 (7.0) 0.003**
(n = 34)§ (n = 23)§
CIRS score 9.0 (4.0) 8.9 (3.7) 0.850**
HbA1c***, % 6.1 (0.4) 8.1 (1.2) 0.007**
Diabetes-related complications, n (%) 22.0 (33.0) 15.0 (50.0) 0.120†
Notes: *Unless otherwise indicated, data are given as mean (SD); †P-value was based on Chi-square test; **P-value was based on t-test; ***Average of two measurements; 
§Number of patients for whom information on diabetes duration was available.
Abbreviations: HbA1c, glycosylated hemoglobin; CIRS, cumulative illness rating scale.Diabetes, Metabolic Syndrome and Obesity 2008:1 36
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attention in primary care encounters (Parchman et al 2007). 
Therefore, in the presence of multiple comorbid conditions, 
diabetic patients may receive better care. As a matter of fact, 
it has been reported that vulnerable elders with multiple 
chronic conditions, including diabetes, receive better over-
all quality of care (Min et al 2007), and that the quality of 
care improves as a patient’s number of chronic conditions 
increases (Higashi et al 2007).
Limitations
It could have been preferable to use a mean value of all HbA1c 
over two years rather than using only the most recent two 
HbA1c measures. However, given data abstraction techniques, 
it was not feasible to utilize additional values. Since we per-
formed a retrospective study, one limitation of our method 
is that different variables such as the time elapsed between 
the two measurements of HbA1c could not be controlled. 
Furthermore, in our sample, 69% of the patients had a good 
glycemia control (Table 1), a higher proportion compared 
to that in other studies (33%–55%) (Weiner and Long 2004; 
Meduru et al 2007; Suh et al 2008). The fact that our institu-
tion is a teaching hospital with a FMU may have inﬂ  uenced 
the quality of care provided, and biased the results towards 
a better glycemia control. There is also the possibility that a 
number of patients with more severe diabetes are followed 
up in specialized clinics and were therefore underrepresented 
in our sample. Another limitation of the study is that the 
patients were recruited from only one setting and therefore 
extrapolation of our results to other settings is more difﬁ  cult 
to make.
Lack of statistical power could be an issue in the 
assessment of the relationship between diabetes-related 
complications and glycemia control. Given that the propor-
tion of complications is around 50% when diabetes is not 
controlled, the two group chi-square test at the 0.05 level had 
a 34% statistical power to detect an odds ratio of 0.5 with 
sample sizes of 30 (uncontrolled diabetes) and 66 (controlled 
diabetes) (nQuery Advisor 6.01).
Despite these limitations, our study is strengthened by 
the use of a comprehensive comorbidity index to measure 
comorbidity that takes into account disease severity, a ran-
dom patients’ selection and the mean of two HbA1c measure-
ments instead of a single measurement.
Conclusion
Our study suggests that comorbidity, measured with an 
exhaustive index, is not a factor that prevents the achievement 
of a good glycemia control in patients with type 2 diabetes. 
Further studies are needed to extend these results to other 
settings and to evaluate the impact of different types of 
medical conditions on glycemia control.
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